Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

133.50
BATS BZX Real-Time Price
As of 3:55pm ET
 +0.10 / +0.07%
Today’s Change
96.18
Today|||52-Week Range
145.42
+9.11%
Year-to-Date
Falling Earnings Estimates Signal Weakness Ahead for Adamas (ADMS)
9:39am / Zacks.com - Paid Partner Content
Ardsley Advisory Partners Buys Alexion Pharmaceuticals Inc, Silver Spring Networks In...
Aug 14 / GuruFocus News - Paid Partner Content
Mirati Therapeutics (MRTX) Rises: Stock Moves 10.9% Higher
8:49am / Zacks.com - Paid Partner Content
Regeneron vs. Alexion: Which Stock is a Better Pick Post Q2 Earnings?
Aug 14 / Zacks.com - Paid Partner Content
Horizon Pharma (HZNP) Soars: Stock Adds 10.5% in Session
Aug 18 / Zacks.com - Paid Partner Content
Editas Medicine (EDIT) Looks Good: Stock Moves Up 11.3%
Aug 14 / Zacks.com - Paid Partner Content
Seattle Genetics' Adcetris Granted Priority Review by FDA
Aug 17 / Zacks.com - Paid Partner Content
Forget Teva (TEVA), Buy These 4 Drug Stocks Instead
Aug 11 / Zacks.com - Paid Partner Content
Novo Nordisk's Semaglutide Shows Remarkable Results in Study
Aug 17 / Zacks.com - Paid Partner Content
Implied Volatility Surging for Alexion Pharmaceuticals (ALXN) Stock Options
Aug 11 / Zacks.com - Paid Partner Content
Spectrum (SPPI) Initiates Phase II Study for Cancer Drug
Aug 16 / Zacks.com - Paid Partner Content
Puma (PBYI) Q2 Loss Narrower than Expected, Nerlynx in Focus
Aug 10 / Zacks.com - Paid Partner Content
Shire Files Marketing Application for Lifitegrast in Europe
Aug 16 / Zacks.com - Paid Partner Content
Geron (GERN) Q2 Loss Narrows, Sales Miss Estimates, Stock Up
Aug 10 / Zacks.com - Paid Partner Content
Daniel Loeb Buys 8 Stocks in 2nd Quarter
Aug 16 / GuruFocus News - Paid Partner Content
Forget Bayer, Buy These 3 Drug Stocks Instead
Aug 08 / Zacks.com - Paid Partner Content
MiMedx Group (MDXG) in Focus: Stock Moves 6.1% Higher
Aug 16 / Zacks.com - Paid Partner Content
Dynavax Technologies (DVAX) Catches Eye: Stock Adds 11.2% in Session
Aug 08 / Zacks.com - Paid Partner Content